Lexaria Bioscience reports Form D covering warrant exercise proceeds
The Kelowna-based biotechnology company disclosed $113,492 in proceeds from a warrant inducement arrangement in a Form D filed with the SEC.
SEC filing
Latest
2 stories
Friday, September 18
Wednesday, September 9
Lexaria raises about $5.9 million through warrant exercise inducement deal
Holders agreed to immediately exercise existing warrants at a reduced price, with H.C. Wainwright acting as placement agent for the September 9, 2026 closing.
SEC filing